clinical trial · NCT06792552
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Advanced Solid TumorsSIM0505 for injectionSIM0505 for injection
brief summary
This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
started
Feb 26, 2025
primary completion
Feb 1, 2028
completion
Aug 1, 2028
last updated
Jan 29, 2026
official title
A Phase I First-in-human, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol